Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Edwards Lifesciences Corp (EW)

  7. Edwards Lifesciences Corp (EW) News

EW

Edwards Lifesciences Corp
81.815
0.175 (0.21%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Edwards Lifesciences Corp EW NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.175 0.21% 81.815 09:42:33
Open Price Low Price High Price Close Price Prev Close
82.30 81.78 82.60 81.64
more quote information »

Recent News

Date Time Source Heading
3/29/20232:01IHNWFeatured1606 Corp Announces Pivotal Distribution Deal With a Premier CBD Distributor
3/28/202316:41EDGARProxy Statement (definitive) (def 14a)
3/28/202316:33EDGARAnnual Report to Security Holders (ars)
3/28/202316:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/28/202316:19EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/08/202317:57EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202309:00PRNUSEDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME..
2/21/202316:31EDGARCurrent Report Filing (8-k)
2/16/202318:22EDGARStatement of Changes in Beneficial Ownership (4)
2/15/202318:21EDGARStatement of Changes in Beneficial Ownership (4)
2/13/202318:34EDGARAnnual Statement of Changes in Beneficial Ownership (5)
2/13/202318:34EDGARAnnual Statement of Changes in Beneficial Ownership (5)
2/13/202316:35EDGARAnnual Report (10-k)
2/07/202314:12EDGARAmended Statement of Ownership (sc 13g/a)
1/31/202316:32EDGARCurrent Report Filing (8-k)
1/31/202316:15PRNUSEDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
1/24/202307:05PRNUSEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON..
1/17/202318:18EDGARStatement of Changes in Beneficial Ownership (4)
1/13/202318:42EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202318:41EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202309:05PRNUSEDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P...
12/15/202218:13EDGARStatement of Changes in Beneficial Ownership (4)
12/14/202218:51EDGARStatement of Changes in Beneficial Ownership (4)
12/13/202217:29EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202220:45TRMNRBC Capital Remains a Buy on Edwards Lifesciences (EW)
12/12/202218:30EDGARStatement of Changes in Beneficial Ownership (4)
12/08/202217:28EDGARCurrent Report Filing (8-k)
12/08/202209:25TRMNBTIG Reaffirms Their Hold Rating on Edwards Lifesciences..
12/08/202208:56DJNEdwards Lifesciences CEO Michael Mussallem to Retire
12/08/202208:01PRNUSEDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL..
12/08/202208:00PRNUSEDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN
11/27/202210:25PRNUSEDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL..
11/15/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
11/08/202218:02EDGARStatement of Changes in Beneficial Ownership (4)
11/08/202218:02EDGARStatement of Changes in Beneficial Ownership (4)
11/03/202221:15TRMNCredit Suisse Sticks to Its Hold Rating for Edwards..
11/01/202209:14EDGARCurrent Report Filing (8-k)
11/01/202209:00PRNUSEDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED..
11/01/202202:56TRMNEdwards Lifesciences (EW) Receives a Buy from Stifel..
10/28/202216:23EDGARQuarterly Report (10-q)
10/28/202212:36TRMNMorgan Stanley Keeps Their Buy Rating on Edwards..
10/28/202211:40DJNEdwards Lifesciences Down Nearly 18%, on Pace for Largest..
10/28/202210:43DJNEdwards Lifesciences Shares Slide After Earnings Miss,..
10/28/202200:25TRMNBTIG Sticks to Their Hold Rating for Edwards Lifesciences..
10/27/202216:23EDGARCurrent Report Filing (8-k)
10/27/202216:15PRNUSEDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
10/20/202207:05PRNUSEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON..
10/14/202219:11EDGARStatement of Changes in Beneficial Ownership (4)
10/14/202219:03EDGARStatement of Changes in Beneficial Ownership (4)
10/11/202218:23EDGARStatement of Changes in Beneficial Ownership (4)
10/07/202214:03EDGARReport of Proposed Sale of Securities (144)